May 10, 2017 / 11:20 AM / 2 months ago

BRIEF-Clearside Biomedical Q1 loss per share $0.41

1 Min Read

May 10 (Reuters) - Clearside Biomedical Inc

* Clearside biomedical, inc. Announces first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.41

* Q1 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S

* Clearside biomedical inc- qtrly research & development expenses for three months ended march 31, 2017 were $7.6 million, compared to $4.6 million for q1 of 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below